Développement de thérapies par équipe de maladies – Recherche Université de Californie, Davis Traitement de l'ostéonécrose non traumatique avec des cellules souches mésenchymateuses endogènes ...

Jonathan Thomas, PhD, JD, is President and CEO of the California Institute for Regenerative Medicine (CIRM). Thomas was previously the Chair of the CIRM governing Board from June 2011 to March 2023.

A major challenge in developing stem cell-based cures for disease is maturing those cells into adult cell types that can be used for transplantation or to study human disease. Dr. Mark Mercola has a ...

The simple term “stem cell” actually refers to many different types of cells. The tissue-specific stem cells, or adult stem cells, replenish tissues throughout our lives. Embryonic stem cells exist ...

我们的目标是利用生成神经元网络的机制从干细胞创建神经元，以替代患病和受损的组织或作为研究疾病机制的材料来源。此类再生研究的一个重点是恢复脊髓的功能，因为脊髓特别容易受到 ...

Las reuniones de la CFAOC están organizadas por la Oficina del Contralor del Estado. A continuación, se incluye una copia de la agenda publicada en https://www.sco ...

CIRM is governed by 35 dedicated Californians representing patients, researchers and the biotechnology industry whose knowledge, passion and commitment to CIRM’s mission has guided the organization ...

https://im.csgsystems.com/cgi-bin/confCast Enter Conference ID# 457698 Then click Go. 3. Discussion of Personnel [Evaluation of President] (Government Code section ...

If you would like to contact CIRM regarding questions you may have about employment opportunities, please contact us at jobs@cirm.ca.gov. CIRM encourages job seekers to apply for specific job openings ...

San Francisco, CA – California’s stem cell agency, the California Institute for Regenerative Medicine (CIRM) today approved $150 million in new funding to help move promising stem cell-based therapies ...

CIRM has one singular mission: Accelerating world class science to deliver transformative regenerative medicine treatments in an equitable manner to a diverse California and world. A dedication to ...

Our Agency funds clinical trials testing promising stem cell or gene therapies for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem ...